EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Effectiveness and Cost-Effectiveness of the Tankevirus and Grubl Mental Health Apps Compared With a Placebo App—Mental Health Intervention With Digital Applications (MIND-APP): Protocol for a Randomized Controlled Researcher-Blinded Trial

Kim Rand iD, Julia Menichetti iD, Torbjørn Wisløff iD, Hanne Helene Brorson iD

JMIR Research Protocols · 10.08.2026 · 15 · e84096

DOI: 10.2196/84096 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JMIR Research Protocols, online erschienen am 10.08.2026. Verfasst von Kim Rand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Mobile Applications, Cognitive Behavioral Therapy. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anxiety and depression impose substantial clinical and economic burdens worldwide, with high prevalence, impaired functioning, and elevated health care costs. Digital self-help interventions offer scalable and potentially cost-effective strategies; however, evidence from rigorously controlled economic evaluations remains sparse.

Objective

This trial aims to evaluate the effectiveness and cost-effectiveness of 2 Norwegian mental health apps: Tankevirus (cognitive behavioral therapy–based) and Grubl (metacognitive therapy–based), compared with a digital placebo in reducing anxiety and depression symptoms, improving health-related quality of life, and generating quality-adjusted life years.

Methods

The Mental Health Intervention With Digital Applications (MIND-APP) trial is a 3-arm randomized controlled trial (1:1:1 allocation) conducted fully remotely via a bespoke smartphone research platform. A total of 1000 Norwegian residents aged 16 years or older with mild to moderate symptoms of anxiety and/or depression will be recruited through national digital outreach. Coprimary outcomes are changes in anxiety (Generalized Anxiety Disorder-7) and depression (Patient Health Questionnaire-9) scores from baseline to postintervention (2-4 weeks). Secondary outcomes include health-related quality of life (EQ-5D-5L), quality-adjusted life years accrued over 6 months, functional impairment (Work and Social Adjustment Scale), health care resource use, and adverse events. Incremental cost-effectiveness ratios for Tankevirus and Grubl relative to placebo will be estimated from the perspective of public health services.

Results

Funding was secured in April 2025, with ethical approvals, licensing, and app development planned through 2026. Recruitment will commence in 2027, with follow-up through 2027 and early 2028. An extension of the timetable has been approved by the funding agent to allow inclusion of an updated version of the Tankevirus app, which will be ready for testing around May 2027. Results are expected to be published in autumn 2028 and will provide robust evidence on the clinical and economic value of scalable app-based interventions for common mental health disorders.

Conclusions

This trial will be among the first large-scale registered reports to combine rigorous clinical and economic evaluation of digital mental health interventions. Findings will inform health policy and resource allocation by determining whether low-cost, app-based programs represent cost-effective solutions for reducing the burden of anxiety and depression. Trial Registration ClinicalTrials.gov NCT07627204; https://clinicaltrials.gov/study/NCT07627204 International Registered Report Identifier (IRRID) PRR1-10.2196/84096

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mobile ApplicationsCognitive Behavioral TherapyHumansCost-Benefit AnalysisCost-Effectiveness AnalysisRandomized Controlled Trials as TopicNorwayQuality of LifeMental HealthQuality-Adjusted Life YearsAnxietyDepressionFemaleMaleAdult

Stichwörter der Autor:innen

NorwayQALYsanxietycognitive behavioral therapycost-effectivenessdepressiondigital healthmetacognitive therapyquality-adjusted life yearsrandomized controlled trialself-helptelephone app

Autor:innen und Institutionen

  • Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
  • Maths in Health BV, Klimmen, The Netherlands.
  • Brorson & Sande AS, Oslo, Norway.

ORCID-Profile: Kim Rand, Julia Menichetti, Torbjørn Wisløff, Hanne Helene Brorson

Zitieren

APA

Rand, K., Menichetti, J., Wisløff, T., & Brorson, H. H. (2026). Effectiveness and Cost-Effectiveness of the Tankevirus and Grubl Mental Health Apps Compared With a Placebo App—Mental Health Intervention With Digital Applications (MIND-APP): Protocol for a Randomized Controlled Researcher-Blinded Trial. JMIR Research Protocols, 15, e84096. https://doi.org/10.2196/84096

Vancouver

Rand K, Menichetti J, Wisløff T, Brorson HH. Effectiveness and Cost-Effectiveness of the Tankevirus and Grubl Mental Health Apps Compared With a Placebo App—Mental Health Intervention With Digital Applications (MIND-APP): Protocol for a Randomized Controlled Researcher-Blinded Trial. JMIR Research Protocols. 2026;15:e84096. doi:10.2196/84096

BibTeX
@article{Rand2026,
  author = {Rand, Kim and Menichetti, Julia and Wisløff, Torbjørn and Brorson, Hanne Helene},
  title = {Effectiveness and Cost-Effectiveness of the Tankevirus and Grubl Mental Health Apps Compared With a Placebo App—Mental Health Intervention With Digital Applications (MIND-APP): Protocol for a Randomized Controlled Researcher-Blinded Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e84096},
  doi = {10.2196/84096}
}
Kostenlos starten →